P
Puliyan Medical Technology
Regenerative aesthetic medical device developer and manufacturer
About Puliyan Medical Technology
Puliyan Medical Technology, founded in May 2018, is a high-tech medical enterprise based in Nanjing, China, that integrates research and development, production, sales, and service. The company specializes in the regenerative aesthetics market, focusing on developing products that stimulate the body's natural healing processes for long-term improvements in skin health. This approach differs from traditional medical aesthetics that may offer more immediate but shorter-lived results.
The company has successfully obtained two Class III medical device registration certificates from China's National Medical Products Administration (NMPA), the highest risk category requiring stringent documentation and regulatory adherence. This certification has enabled the commercialization of two key products: a collagen-stimulating injectable for deep-tissue regeneration and wrinkle correction, and a thread-lifting product for a minimally invasive lift by stimulating collagen production. Puliyan's product pipeline includes items like collagen water-light needles and long-acting collagen implants, with a focus on using bio-derived, recycled materials.
In July 2025, Puliyan secured $50 million in a Series C funding round led by Mirae Asset Capital (China), with participation from returning investors Alwin Capital and Huatai Zijin Investment. The firm operates a production facility of over 4,000 square meters, which includes a 1,000-square-meter clean factory, automated production equipment, and a central laboratory to ensure quality control.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 25.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Surgery, Dermatology, Advanced Materials, wound care, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jul 2025 | $50M | $200M | Huatai Zijin Investment · Mirae Asset Securities (HK) · Alwin Capital | ↗ |
Growth signals
Latest recorded traffic for Puliyan Medical Technology is 280 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
BioactivxSynthetic, regenerative biomaterials for advanced wound care |
Singapore | Operational | 6 | $4.4M | $12M |
Shanghai Ruining BiotechnologyMedical hydrogel products for oncology and intervention |
China | Operational | |||
| Osaka, Japan | Operational | ||||
| Klamath Falls, United States | Operational | ||||
| Suzhou Shi, China | Operational | ||||
MedifabBiomaterial and 3D bioprinting for tissue regeneration |
Seoul, South Korea | Operational | |||
ApproximaThe first minimally invasive treatment tailored for the tricuspid valve |
Milan, Italy | Operational | |||
OPTIMOTION IMPLANTSTHE NEXT GENERATION TOTAL KNEE REPLACEMENT |
Orlando, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Puliyan Medical Technology in the Nanjing City ecosystem
The Puliyan Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Mirae Asset Securities (HK)
Huatai Zijin Investment- ACAlwin Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Puliyan Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Puliyan Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







